Comparison of the Accuracy of Noninvasive Hemoglobin Sensor (NBM-200) and Portable Hemoglobinometer (HemoCue) with an Automated Hematology Analyzer (LH500) in Blood Donor Screening

• Published in: Annals of laboratory medicine Vol. 33; no. 4; pp. 261 - 267
• Main Authors: Kim, Moon Jung, Park, Quehn, Kim, Myung Hee, Shin, Jeong Won, Kim, Hyun Ok
• Format: Journal Article
• Language: English
• Published: Korea (South) The Korean Society for Laboratory Medicine 01.07.2013; 대한진단검사의학회
• Subjects: Automation; Biosensing Techniques - instrumentation; Blood Chemical Analysis - instrumentation; Blood Donors; Donor Selection - methods; Female; Hemoglobins - analysis; Humans; Male; Original; Sensitivity and Specificity; 병리학; Hemoglobin; Donor selection; Safety management; Blood donors
• ISSN: 2234-3806; 2234-3814; 2234-3814
• DOI: 10.3343/alm.2013.33.4.261

The Hb levels of prospective blood donors are usually determined using a finger prick test. A new noninvasive Hb device has the advantage of not causing any sampling pain. The purpose of this study was to evaluate the accuracy of the noninvasive Hb sensor and to compare its measurements with those of a currently used portable hemoglobinometer. Hb was measured using a noninvasive Hb sensor (NBM-200; OrSense, Israel), a portable hemoglobinometer (HemoCue; HemoCue AB, Sweden), and an automated hematology analyzer (LH500; Beckman Coulter, USA). The correlations between Hb measurements taken by the NBM-200 and HemoCue with those by an automated hematology analyzer were assessed using intraclass correlation coefficients (ICCs). Hb measurements were compared among 3 different Hb level groups. The mean Hb values of 506 blood donors were 14.1 g/dL by the NBM-200, 14.0 g/dL by the LH500, and 14.3 g/dL by the HemoCue. The correlation between the LH500 and the NBM-200 was substantial (ICC=0.69), while that between the LH500 and the HemoCue agreed almost perfectly (ICC=0.86). The possibility to judge to be eligible for donors who are ineligible to donate was substantial when using NBM-200. Even though the NBM-200 has the apparent advantage of noninvasiveness, its use in pre-screening should be given meticulous attention. Since pre-donation testing is crucial to protecting donors' health, complete evaluation of the instrument should be performed prior to use.